Relay Therapeutics, Inc.
RLAY- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001812364
In the last 90 days, Relay Therapeutics, Inc. insiders filed 0 open-market purchases and 13 sales; 259 institutions reported holding it in 13F filings for Q2 2026, worth $4.58B in total; Duquesne Family Office is the only superinvestor holding it.
Q4 2025 vs. Q3 2025
How the institutions holding Relay Therapeutics, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 199 | 2 | 227 | +30 |
| Shares | 166.2M | 16.3K | 174.1M | +7.90M (+4.8%) |
| Value | $867.4M | $84.7K | $1.47B | +$605.0M (+69.8%) |
2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (50)
Institutions that held Relay Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (20)
Institutions that held Relay Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Tang Capital Management LLC | 8,068,058 | $42.1M |
| Ikarian Capital, LLC | 467,362 | $2.44M |
| Polygon Management Ltd. | 223,123 | $1.16M |
| Boothbay Fund Management, LLC | 137,841 | $719.5K |
| Gsa Capital Partners LLP | 129,422 | $676.0K |
| HSBC Holdings PLC | 98,290 | $504.2K |
| Thrivent Financial for Lutherans | 87,418 | $456.0K |
| Brevan Howard Capital Management LP | 61,629 | $321.7K |
| Diadema Partners LP | 43,616 | $227.7K |
| Federated Hermes, Inc. | 36,000 | $187.9K |
| Blackstone Group Inc. | 35,618 | $185.9K |
| Quinn Opportunity Partners LLC | 30,000 | $156.6K |
| Mariner, LLC | 27,756 | $144.9K |
| Polymer Capital Management (US) LLC | 21,693 | $113.2K |
| Prelude Capital Management, LLC | 19,700 | $102.8K |
| Prudential Financial Inc | 14,825 | $77.4K |
| Boston Family Office LLC | 12,397 | $65.0K |
| Persistent Asset Partners Ltd | 10,280 | $53.7K |
| Optiver Holding B.V. | 1,228 | $6.41K |
| Advisory Services Network, LLC | 81 | $423 |
Not filed for Q4 2025 yet (2)
Institutions that held Relay Therapeutics, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| CIBC Bancorp USA Inc. | 14,116 | $73.7K |
| Shell Asset Management Co | 2,151 | $11.0K |